Monday, October 5, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 476 (TSX: $VIVO.TO) (NASDAQ: $CRON) (TSX: $CRON.TO) (OTCQX: $MRMD) (NEO: MGW) (OTCQB: $MGWFF)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 476 (TSX: $VIVO.TO) (NASDAQ: $CRON) (TSX: $CRON.TO) (OTCQX: $MRMD) (NEO: MGW) (OTCQB: $MGWFF)

Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland

 


Delta, Kelowna, BC, October 5, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/100520-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10051VIVO-CRON-MRMD-MGW-MGWFF.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

In today’s podcast we look at a few public and private company announcements.

VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) today announced it has begun its 2020 season harvest at its Kimmetts facility in Napanee, Ontario, the largest in the Company's history.

 

"I am pleased to say that this year's crop has exceeded our expectations, with some of our plants reaching a height of over 12 feet," said Barry Fishman, CEO of VIVO. "As the only Canadian licensed producer currently using airhouse technology, the success of the crop both validates our strategic decision to invest in the airhouses and demonstrates the capabilities of our highly talented Napanee team."

 

The Kimmetts facility consists of four airhouses with a total of 75,000 square feet of cultivation space, containing approximately 10,000 plants. The harvest, which started one week ahead of schedule due to accelerated plant growth, began with trimming the sections with the largest flowers.

 

The use of airhouse technology results in more reliable cannabis compared with outdoor growing as it mitigates the risk of weather and pest events that can easily destroy an entire outdoor crop. Its benefits over outdoor grow also include improved light quality, controlled air flow and humidity, and the ability to use supplemental heat to extend the growing season as required. Airhouses are inexpensive to erect, easy to sanitize, and simple to maintain. VIVO has the capacity to install additional airhouses in a short timeframe with relatively low capital requirements on its 50+ acre property.

 

VIVO expects to yield approximately 4,000 kilograms from the harvest. Some of the harvest will be packaged and sold as dry flower and the remaining biomass will be extracted in the Company's recently commissioned ethanol extraction hub that has a capacity of handling up to 500 kilograms of biomass per week. After extraction, the Company will process the biomass into its diverse portfolio of Cannabis 2.0 products. Currently VIVO has agreements to sell adult-use products in eight provinces across Canada, and holds a market leadership position in the concentrates category.

 

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRONannounced the launch of its leading medical brand PEACE NATURALS™, in pharmacies throughout Israel through Cronos Israel.

 

Cronos Israel’s operations include the cultivation and production of PEACE NATURALS™ branded products at the company’s facilities, located in Kibbutz Gan Shmuel, in Israel.

 

Currently, Cronos Israel sells dried flower in the medical market and expects to launch cannabis oils and pre-rolls in the near future. As one of the first medicinal cannabis brands in Canada, established in 2013, PEACE NATURALS™ has always stood for high-quality products and a whole health approach to patient care. To maintain consistency, Cronos Israel has imported both dried flower and cannabis plant cuttings from Canada. The Cronos Israel facility now operates independent crop cycles which conform to the characteristics of the products the Company sells in Canada and Germany, and which products are sold in Australia by the Company’s investee, Cronos Australia Limited.

 

Since it was founded in 2018, Cronos Israel has established its cultivation and production facilities, which have received the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production and marketing of dried flowers, pre-rolls and oil drops in Israel. The facilities were built to the same high standards as Cronos Group’s facilities globally, at times voluntarily implementing standards that exceed the Israeli Medical Cannabis Agency (IMCA) requirements for the purpose of providing patients with market-leading cannabinoid products.

 

“We are very excited to be launching in the Israeli market and bringing high-quality medical products to patients. Israel has done a tremendous job creating a viable and successful cannabis market. There is a focus on improving and expediting the patient access process for medical cannabis. The cannabis usage rate in Israel is among the highest in the world, and the medical patient count in Israel is expected to increase rapidly, which represents an excellent opportunity for our business to grow in this market,” said Mike Gorenstein, Executive Chairman, Cronos Group.

 

“The intensive work that went into building our cultivation facility and production line resulted in our ability to grow and produce a high-quality product, based on the unique genetics that have been popular with patients in other parts of the world,” said Rani Gorelik, General Manager, Cronos Israel. “Canada’s innovation and professional expertise, alongside our wonderful team here, have helped us create a product that we are proud of. We are excited to take part in revolutionizing the medical cannabis sector in Israel."

 

MariMed Inc. (OTCQX: MRMD) launched a new line of solventless concentrates under its Nature’s Heritage brand. Live rosin is a highly concentrated solvent-free cannabis hash oil where terpenes and cannabinoids are largely preserved from the natural plant. These Nature’s Heritage concentrates will be available in rotating varieties of sativa, indica, and hybrid strains.

 

“Our live rosin concentrates will provide the best option for the most discerning cannabis consumers and patients in Massachusetts,” said Ryan Crandall, Chief Product Officer and SVP sales at MariMed. “We made a strategic decision to produce this ultra-premium product based upon strong demand for solventless, flavorful, pure, and potent cannabis concentrates from a growing group of consumers. Adding live rosin and other advanced concentrates to our product portfolio will significantly expand our market share and revenue going forward.”

 

Sebastian Pollack, Product Engineer at MariMed, added, “The process of creating live rosin cannot be rushed. Our proprietary process starts with the very best Nature’s Heritage flower and requires a dedicated focus to produce a truly exceptional product. We are confident that this is the highest-quality live rosin consumers can find in Massachusetts today.”

 

Nature’s Heritage has already established itself as one of the top-selling and most sought-after flower brands in Massachusetts and Maryland. The Company is now building on this success with the launch of live rosin and additional products, including other concentrates, a variety of RSO products, vaporizers, and pre-rolls, coming to market over the next several months, all within the Nature’s Heritage brand.

 

Maple Leaf Green World Inc. (NEO: MGW) (OTCQB: MGWFFannounced that it has been granted California Department of Food & Agriculture (“CDFA”) approval for THC testing.

 

THC testing is mandated by the state of California to ensure the crop being harvested does not exceed the legal limit of 0.3% THC. A component of the pre-harvest THC testing involves random samples from any of the Company’s five (5) greenhouses or outdoor grow to be taken by the agricultural commissioner for lab testing. A THC test result exceeding the 0.3% limit would result in an immediate implementation of a corrective action plan which would cause significant delays in harvesting. The Company reported that the CDFA lab report tested at less than 0.3% THC and that with the CDFA approval, the Company can officially sell its La Crème Hemp Products.

 

The company is continuing to harvest and cure its La Crème. The COA sampling collected on Oct 2, 2020 still indicates a pure CBG flower with the CBG concentration increasing to 15.44% from the previous COA at 13.90%. Although this level of CBG is marketable and higher than most strains on the market, the Company will continue to target the 18-20% range on a fully cured flower.

 

 


Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

Disclosure: Cannabis Suisse Corp. (OTC: CSUI), is a paid featured company on Investorideas.com

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

Thursday, October 1, 2020

Investorideas.com - Cannabis Stock News: The Green Organic Dutchman (TSX: $TGOD.TO) (US: $TGODF) Provides Update on Export Pipeline

Investorideas.com - Cannabis Stock News: The Green Organic Dutchman (TSX: $TGOD.TO) (US: $TGODF) Provides Update on Export Pipeline

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - Cannabis Stock News: Canopy Growth (TSX:$WEED.TO) (NYSE:$CGC) and Acreage Holdings (CSE:ACRG.A.U) (CSE: ACRG.B.U), (OTC: ACRHF) (OTC: ACRDF) Announce Initial Plans to Launch THC-Infused Beverages in the U.S. Next Summer

Investorideas.com - Cannabis Stock News: Canopy Growth (TSX:$WEED.TO) (NYSE:$CGC) and Acreage Holdings (CSE:ACRG.A.U) (CSE: ACRG.B.U), (OTC: ACRHF) (OTC: ACRDF) Announce Initial Plans to Launch THC-Infused Beverages in the U.S. Next Summer

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 475 (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $ACRG_A_U.C) (TSX: $TGOD.TO) (CSE: $HAVN.C)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 475 (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $ACRG_A_U.C) (TSX: $TGOD.TO) (CSE: $HAVN.C)

Today’s podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland

 


Delta, Kelowna, BC, October 1, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/100120-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10011WEED-CGC-ACRG-TGOD-HAVN.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

In today’s podcast we look at a few public and private company announcements.

Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) and Acreage Holdings, Inc. (CSE:ACRG.A.U) (OTC: ACRHFannounced today that following the implementation of their amended arrangement, Acreage has developed a plan to market Canopy Growth's diverse beverage portfolio in the United States.

 

Leading with legal adult-use markets in Illinois and California, Acreage anticipates launching Canopy Growth's select, sessionable THC beverage formulations in summer 2021. In addition to selling products in its own dispensaries, Acreage will access existing distribution channels through strategic corporate relationships.

 

"We have had an incredibly successful introduction into the Canadian cannabis-infused beverage industry with over 1.7 million cans of our THC-infused RTD beverages, like Tweed's Houndstooth & Soda and Bakerstreet & Ginger sold to date," shared Canopy Growth CEO, David Klein. "We introduced a new product category to cannabis consumers that we knew had the potential to disrupt one of the most mature industries and since launching in Canada, Canopy Growth now owns 5 of the top 6 SKUs in the beverage category with a 74% market share. We are excited for Canopy's beverages to be introduced to the U.S. market next summer."

 

"We see THC-infused beverages as a game-changer in U.S. cannabis, and we are excited to launch Canopy Growth's unique beverage offerings to our core markets offering the greatest growth potential next year," said Bill Van Faasen, Interim CEO of Acreage Holdings. "We are already working on our beverage production capabilities, and look forward to tapping the wealth of experience and research Canopy can offer following its successful entry in the category last year."

 

The Companies look forward to bringing a sessionable infused beverage offering to U.S. consumers that will more closely liken itself to current beverage-alcohol serving sizes.

 

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), a leading producer of premium certified organically grown cannabis, announced that it has received import licences from the Australian and German authorities, and has applied for export licences with Health Canada.

 

These licences enable TGOD to export its premium certified organically grown products for validation.  The Company anticipates validation will be completed by the end of the year and is on track to commence commercial export of medical cannabis products in 2021.

 

"TGOD was the first certified organic Canadian licensed producer to be granted an EU-GMP certificate.  Today we are one step closer to fulfilling our vision of becoming the leading organic cannabis brand globally," commented Brian Athaide, CEO of TGOD. "Obtaining import licences from Australia and Germany is testament to the robust quality assurance system we have implemented across our operations and supply chain.  We look forward to providing access to our high-quality products to Australian and German patients," added Athaide.

 

TGOD signed a distribution agreement with Australia's LeafCann and has access to a vast network in Europe through its wholly owned subsidiary, TGOD Europe.  The Company expects to complete its first commercial shipment in 2021.

 

LYTE Clinics announced joining the University Health Network and Medical Cannabis by Shoppers in a first-of-its-kind Real World Evidence study with medical cannabis.

 

The Medical Cannabis Real-World Evidence (MC-RWE) clinical trial will allow patients to select medical cannabis products that are tested, from seed straight through to packaging. Patients using the online portal created by Medical Cannabis by Shoppers, will know exactly what is in their product: how many milligrams of THC and cannabidiol are being consumed, and if it works for them, they can rely on the product being exactly the same, from batch to batch. Patients in the MC-RWE clinical trial will have access to a wide range of products including dried flower, oil extracts, edibles, and topical preparations through the portal, which is the online platform for the sale of medical cannabis by Canadian retail pharmacy chain, Shoppers Drug Mart.

 

LYTE Clinics' practitioners will assist patients in enrolling in the study, as well as offering support and medical advice to participants so that they can select the best products for their medical cannabis therapy.

 

LYTE is unique amongst cannabis clinics as the process of scheduling an appointment with a doctor, registering with a medical provider, and placing an order is all done online in a matter of minutes, using state-of-art telehealth software, with the benefit of minimizing wait time.

 

"LYTE's robust telemedicine platform will connect Canada's largest pharmacy network, Shoppers Drug Mart, with Canada's largest and most prestigious research institution, University Health Network, to enable this groundbreaking clinical study in medical cannabis." States Dr Dean Elterman, of University Health Network.

 

"Patients and practitioners need rigorously tested, genetically verified, fully tracked medical cannabis options, noted Ali Mohamed, President & CEO of Lyte Clinics. "The information gathered in the Medical Cannabis Real-World Evidence Study is critical to helping new patients find the type of cannabis that is proven to be best for their symptoms, which will lead to a better quality of life for thousands of Canadians."

 

Havn Life Sciences Inc. (CSE:HAVN), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi, announced that it has joined the Drug Science Medical Psychedelics Working Group consortium.

 

The working group was launched by Drug Science, the UK's leading independent scientific body on drugs that provides an evidence base that is free from political or commercial influence, which creates a foundation for sensible and effective drug laws by delivering, reviewing, and investigating scientific evidence relating to psychoactive drugs.

 

"Havn Life is thrilled to be supporting Drug Science's research on psychedelics," said Dr. Ivan Casselman (Ph.D., FLS), Havn Life's Chief Psychedelic Officer. "We are committed to advancing research in psychedelics, as well as collaborating with organizations and academic institutions around the world to tap into world-class, quality research. The development of sensible drug policy reform is a mission that both the working groups and Havn Life are highly aligned with."

 


Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI ),is a paid featured company on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

#Cannabis #Stock News: Cannabis Suisse Corp. (OTC: $CSUI) Continues Expanding its Horizons in The Field of Online Sales With Shopify (NYSE: $SHOP) as Next Planned Launch @SuisseCorp @Shopify

 

#Cannabis #Stock News: Cannabis Suisse Corp. (OTC: $CSUI) Continues Expanding its Horizons in The Field of Online Sales With Shopify (NYSE: $SHOP) as Next Planned Launch @SuisseCorp  @Shopify

 


Dietikon, Switzerland - October 1, 2020 (Investorideas.com Newswire) Cannabis Suisse Corp. (OTC: CSUI), a fully licensed Swiss cannabis cultivation and distribution company for recreational tobacco products and medical CBD oils, announces online expansion plans including the upcoming launch of its own new retail brand for CBD products.

 

Read this news, featuring CSUI in full at https://www.investorideas.com/CO/CSUI/news/2020/10011Online-Sales-Shopify.asp

 

The Company also reports it has commenced development of its online store on the Shopify (NYSE: SHOP) platform. (https://www.shopify.com/). This builds on previous news of a new hemp line planned for Amazon.com

 

Creating an online store on Shopify will enable the Swiss Company gain a foothold not only in the US market but also expand the boundaries of its real trade, going beyond Europe.

Cannabis Suisse Corp. team has signed a contract and is working with designers and developers to create an online store and a concept for its new brand and plans to announce the official launch shortly.

 

The Company guarantees the quality of the product line that will appear under the new brand name soon. The careful selection of a certified and experienced manufacturer from the United States will be reinforced by independent laboratory studies of each SKU.

COO, Alain Parrik said, "The statistics of online purchases of CBD products and general statistics of online sales are very promising and dynamic. Orders through online distributors in the United States increased 176% in the spring and summer months."

 

"We look to a global leader in Switzerland as a model for a smaller company like ours, with Nestlé Health Science launching a line of broad-spectrum CBD liquids, soft gels, and sprays to U.S. retailers in 2019 and now in September 2020 expanding its distribution of hemp products into Europe. We have ambitious expansion plans."

 

ABOUT CANNABIS SUISSE CORP.

Cannabis Suisse Corp. is a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Cannabis Suisse Corp. to be materially different from the statements made herein.

 

CONTACT:

Alain Parrik
Cannabis Suisse Corp.
+41445865314
alain.parrik@cannabissuisse.biz

 

SOURCE: Cannabis Suisse Corp

 

Cannabis Suisse (OTC: CSUI) is a featured Cannabis stock on Investorideas.com

 

Visit profile page

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

Disclosure : Cannabis Suisse Corp. (OTC: CSUI) is a paid monthly cannabis company on Investorideas.com ( five thousand per month) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

 



 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

Buy a cannabis guest post on Investorideas.com